[20210819]IF11905_与2019冠状病毒疾病疫苗生产和全球分销相关的责任问题.pdf

https:/crsreports.congress.gov August 19, 2021Liability Issues Related to COVID-19 Vaccine Manufacturing and Global DistributionBackground In March 2021, the United States announced efforts to donate Coronavirus Disease 2019 (COVID-19) vaccines abroad. In many high-income countries, vaccines and other medical countermeasures are playing a critical role in controlling the spread of COVID-19. Vaccine distribution efforts in low- and middle-income countries (LMICs) have been comparatively slow for a variety of reasons, raising concerns about how inequities may hinder pandemic control. Some vaccine manufacturers and others willing to donate COVID-19 vaccines are concerned about legal exposure should there be adverse health events arising from COVID-19 vaccination outside of the United States. For example, U.S. government vaccine donations to India reportedly remain in a Delhi warehouse because the Indian government has not agreed to indemnify vaccine manufacturers for vaccine-related injuries. Only a relatively small percentage of the Indian population is fully vaccinated against COVID-19; donated doses could potentially increase vaccination rates in the country. This In Focus discuss